why choose us

First received: March 16, 2023

Clinical Trial: Three-pronged Centralized Molecular Analysis to Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Thyroid Cancer

Study Type: OBSERVATIONAL


Official Title: A Multi-institutional Effort With a Three-pronged Centralized Molecular Analysis to Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

Brief Summary: This multi-center study aims at NTRK fusion testing of all patients with advanced thyroid cancer (any histotype and regardless of stage).The primary objective of this study is to assess the frequency of NTRK fusions in thyroid cancer.The secondary objective of this study is to develop an effective tool (testing) strategy for the detection of NTRK fusions in thyroid tumors, comparing the diagnostic tecniques available (IHC, real-time PCR and NGS).

Read more